In terms of medications, patients who were on maximal doses of ACE inhibitor/ARB demonstrated significantly increased odds of CKD progression compared to those who were not on ACE inhibitor/ARB (OR: 1.28, 95% CI 1.07, 1.53) (Table 2). Here, ACE is linked to chronic kidney disease.